| 0.15 Data as of 11:40am ET |  0.00 / 0.00%Today’s Change | 0.06 Today|||52-Week Range 0.23 | -8.54% Year-to-Date |
| Previous close | 0.15 |
| Today’s open | 0.13 |
| Day’s range | 0.13 - 0.15 |
| Volume | 200 |
| Average volume (3 months) | 27,463 |
| Market cap | $54.4M |
| Dividend yield | -- |
| Earnings growth (last year) | +50.00% |
| Earnings growth (this year) | -37.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -19.45% |
| P/E ratio | NM |
| Price/Sales | 7.74 |
| Price/Book | 9.05 |
| Today’s change | Today’s % change | |
|---|---|---|
| --MetaStat Inc | 0.00 | 0.00% |
| CGIXCancer Genetics Inc | -0.01 | -0.09% |
| PANGPanacea Global Inc | 0.00 | 0.00% |
| ERBERBA Diagnostics Inc | -0.05 | -5.26% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -$0.00 |
| Annual revenue (last year) | $7.6M |
| Annual profit (last year) | -$2.2M |
| Net profit margin | -29.40% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Steve T. Laflin |
Chief Financial Officer & Secretary Laurie A. McKenzie-Carter, CPA |
Corporate headquarters Idaho Falls, Idaho |
.
